FindMyRecallSubscribe
Class I: serious health riskTerminated

Premiere Sales Group Rhino 7 3000 Recall

Rhino 7 3000, 6 count Bottle, Distributed by Rhino 7, Made in USA

Premiere Sales Group · Santa Clarita, CA

Risk level
Class I
Reported by FDA
Feb 24, 2016
Recall ID
D-0672-2016
Check your lot numberHow we source this data

Summary

Premiere Sales Group recalled Rhino 7 3000 starting Sep 30, 2015. The FDA classified it as Class I (serious health risk) and published enforcement report D-0672-2016 on Feb 24, 2016. Reason: Marketed without an Approved NDA/ANDA: Products contain undeclared active pharmaceutical ingredients; desmethyl carbondenafil and dapoxetine. Status: Terminated.

Why it was recalled

Marketed without an Approved NDA/ANDA: Products contain undeclared active pharmaceutical ingredients; desmethyl carbondenafil and dapoxetine.

Product description

Rhino 7 3000, 6 count Bottle, Distributed by Rhino 7, Made in USA

Lot numbers, UPCs & expiration codes

All lots

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0672-2016
Classification
Class I
Status
Terminated
Recall initiated
Sep 30, 2015
FDA report date
Feb 24, 2016
Quantity
337 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Premiere Sales Group

Original FDA data

Every field from FDA enforcement report D-0672-2016, exactly as published.

Show all FDA fields
City
Santa Clarita
State
CA
Status
Terminated
Country
United States
Event ID
72522
Address
21446 Golden Triangle Rd
Code information
All lots
Postal code
91350-2911
Report date
Feb 24, 2016
Product type
Drugs
Recall number
D-0672-2016
Classification
Class I
Recalling firm
Premiere Sales Group
Product quantity
337 bottles
Termination date
Jun 1, 2017
Reason for recall
Marketed without an Approved NDA/ANDA: Products contain undeclared active pharmaceutical ingredients; desmethyl carbondenafil and dapoxetine.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Rhino 7 3000, 6 count Bottle, Distributed by Rhino 7, Made in USA
Distribution pattern
Nationwide
Recall initiation date
Sep 30, 2015
Initial firm notification
E-Mail
Center classification date
Feb 16, 2016

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0672-2016, published Feb 24, 2016. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls